SG47152A1 - Naphthalene derivatives process for the preparation thereof and intermediates therefor - Google Patents

Naphthalene derivatives process for the preparation thereof and intermediates therefor

Info

Publication number
SG47152A1
SG47152A1 SG1996010041A SG1996010041A SG47152A1 SG 47152 A1 SG47152 A1 SG 47152A1 SG 1996010041 A SG1996010041 A SG 1996010041A SG 1996010041 A SG1996010041 A SG 1996010041A SG 47152 A1 SG47152 A1 SG 47152A1
Authority
SG
Singapore
Prior art keywords
preparation
naphthalene derivatives
intermediates therefor
derivatives process
intermediates
Prior art date
Application number
SG1996010041A
Other languages
English (en)
Inventor
Katsuo Ikezawa
Shinsuke Yamagata
Tatsuzo Ukita
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of SG47152A1 publication Critical patent/SG47152A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SG1996010041A 1995-06-15 1996-06-11 Naphthalene derivatives process for the preparation thereof and intermediates therefor SG47152A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14928895 1995-06-15

Publications (1)

Publication Number Publication Date
SG47152A1 true SG47152A1 (en) 1998-03-20

Family

ID=15471914

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996010041A SG47152A1 (en) 1995-06-15 1996-06-11 Naphthalene derivatives process for the preparation thereof and intermediates therefor

Country Status (21)

Country Link
US (3) US6005106A (de)
EP (1) EP0748805B1 (de)
KR (1) KR100435247B1 (de)
CN (1) CN1063748C (de)
AR (1) AR002483A1 (de)
AT (1) ATE164843T1 (de)
AU (1) AU706156B2 (de)
BG (1) BG62521B1 (de)
BR (1) BR9602802A (de)
CA (1) CA2178974C (de)
DE (1) DE69600221T2 (de)
ES (1) ES2116131T3 (de)
HK (1) HK1010116A1 (de)
HU (1) HU222340B1 (de)
IL (1) IL118469A (de)
MY (1) MY121606A (de)
NO (1) NO310109B1 (de)
RU (1) RU2129120C1 (de)
SG (1) SG47152A1 (de)
TW (1) TW349098B (de)
ZA (1) ZA964652B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID19155A (id) * 1996-12-13 1998-06-18 Tanabe Seiyaku Co Turunan-turunan piridin, pembuatannya dan intermediet untuk pembuatannya
JPH1171351A (ja) * 1997-08-29 1999-03-16 Ss Pharmaceut Co Ltd 置換キノロン誘導体及びこれを含有する医薬
US20050147534A1 (en) 1998-05-05 2005-07-07 Massachusetts Institute Of Technology Emissive sensors and devices incorporating these sensors
ATE409215T1 (de) 1998-05-05 2008-10-15 Massachusetts Inst Technology Emittierende polymere und vorrichtungen diese polymere enthaltend
EP1212089B1 (de) 1999-08-21 2006-03-22 ALTANA Pharma AG Synergistische kombination von roflumilast und salmeterol
ES2427930T3 (es) 2001-05-23 2013-11-04 Mitsubishi Tanabe Pharma Corporation Composición terapéutica para el tratamiento regenerativo de enfermedades de los cartílagos
KR20040007596A (ko) * 2001-05-23 2004-01-24 다나베 세이야꾸 가부시키가이샤 골절 치료 촉진용 조성물
TWI221838B (en) 2001-08-09 2004-10-11 Tanabe Seiyaku Co Pyrazinoisoquinoline compound or naphthalene compound
MXPA04005427A (es) * 2001-12-10 2005-04-19 Amgen Inc Ligandos de receptor vainilloide y su uso en tratamientos.
US20050043315A1 (en) * 2002-01-02 2005-02-24 Hideo Tsutsumi Aminopyrimidine compounds, processes for their preparation and pharmaceutical compositions containing them
WO2003099284A1 (en) * 2002-05-22 2003-12-04 Amgen Inc. Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
BR0313255A (pt) * 2002-08-08 2005-07-12 Amgen Inc Composto, composição farmacêutica, uso de um composto e métodos de fabricar um medicamento e de preparar um composto
WO2004080966A1 (ja) 2003-03-14 2004-09-23 Ono Pharmaceutical Co., Ltd. 含窒素複素環誘導体およびそれらを有効成分とする薬剤
MXPA05010373A (es) 2003-04-01 2005-12-05 Applied Research Systems Inhibidores de fosfodiesterasas en infertilidad.
CA2525843A1 (en) * 2003-05-16 2004-12-02 University Of Chicago Optical fractionation methods and apparatus
AU2004278382B2 (en) * 2003-09-30 2008-09-18 Amgen Inc. Vanilloid receptor ligands and their use in treatments
MY139645A (en) * 2004-02-11 2009-10-30 Amgen Inc Vanilloid receptor ligands and their use in treatments
JP2007522233A (ja) * 2004-02-11 2007-08-09 アムジエン・インコーポレーテツド バニロイド受容体リガンド及び治療におけるそれらの使用
EP1790637B1 (de) 2004-09-13 2014-01-29 Ono Pharmaceutical Co., Ltd. Derivate von N-4-Piperidylharnstoff und diese als Wirkstoff enthaltende Medikamente
WO2006034081A2 (en) 2004-09-17 2006-03-30 Massachusetts Institute Of Technology Polymers for analyte detection
TWI339578B (en) 2004-10-29 2011-04-01 Mitsubishi Tanabe Pharma Corp Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions
WO2006089311A1 (en) * 2005-02-15 2006-08-24 Amgen Inc. Vanilloid receptor ligands and their use in treatments
US20060235036A1 (en) * 2005-04-15 2006-10-19 Doherty Elizabeth M Vanilloid receptor ligands and their use in treatments
PT2371820E (pt) * 2005-10-04 2013-10-16 Mitsubishi Tanabe Pharma Corp Composto de álcool cíclico opticamente activo e método para a sua preparação
WO2007040238A1 (ja) 2005-10-04 2007-04-12 Mitsubishi Tanabe Pharma Corporation 光学活性4-ヒドロキシ-1,2,3,4-テトラヒドロキノリン化合物の製法
WO2007043426A1 (ja) 2005-10-05 2007-04-19 Mitsubishi Tanabe Pharma Corporation 皮膚炎治療剤
KR20090008217A (ko) 2006-03-10 2009-01-21 오노 야꾸힝 고교 가부시키가이샤 질소 함유 복소환 유도체 및 이들을 유효 성분으로 하는 약제
WO2007112347A1 (en) * 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
WO2008042289A2 (en) 2006-09-29 2008-04-10 Massachusetts Institute Of Technology Polymer synthetic technique
US8802447B2 (en) 2006-10-05 2014-08-12 Massachusetts Institute Of Technology Emissive compositions with internal standard and related techniques
US20090215189A1 (en) 2006-10-27 2009-08-27 Massachusetts Institute Of Technology Sensor of species including toxins and chemical warfare agents
EP1958947A1 (de) * 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitoren für Phosphodiesterase Typ 4
EP2144916A4 (de) * 2007-04-10 2012-01-04 Univ Pennsylvania Phen-naphthalen- und phen-chinolinderivate und ihre verwendung zur bindung und abbildung von amyloider plaque
US9125807B2 (en) 2007-07-09 2015-09-08 Incept Llc Adhesive hydrogels for ophthalmic drug delivery
EP2727594B1 (de) * 2011-06-28 2017-12-20 Mitsubishi Tanabe Pharma Corporation Naphtalene verbindungen zur behandlung von juckreiz
JPWO2013027835A1 (ja) 2011-08-25 2015-03-19 田辺三菱製薬株式会社 光学活性ナフタレン化合物の製法
US11970440B1 (en) 2023-10-30 2024-04-30 King Faisal University 8-(3-chlorobenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound
US11932593B1 (en) 2023-10-31 2024-03-19 King Faisal University 8-(3-bromobenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound
US11987543B1 (en) 2023-10-31 2024-05-21 King Faisal University 8-(4-bromobenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8502573D0 (sv) * 1985-05-23 1985-05-23 Jouko Kanakre Fluorescent lanthanide chelates useful as labels of physiologically active materials
JP3042156B2 (ja) * 1992-02-20 2000-05-15 田辺製薬株式会社 ナフタレン誘導体、その製法及びその合成中間体
US5342841A (en) * 1992-03-12 1994-08-30 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivatives
EP0731084B1 (de) * 1995-03-03 2002-09-25 Rolic AG Photovernetzbare Naphthylderivate

Also Published As

Publication number Publication date
IL118469A (en) 2000-08-13
US6005106A (en) 1999-12-21
TW349098B (en) 1999-01-01
KR970001343A (ko) 1997-01-24
KR100435247B1 (ko) 2004-09-10
AR002483A1 (es) 1998-03-25
BG100656A (en) 1997-09-30
NO962527D0 (no) 1996-06-14
US6214996B1 (en) 2001-04-10
AU5469396A (en) 1997-01-02
DE69600221D1 (de) 1998-05-14
NO310109B1 (no) 2001-05-21
CN1142497A (zh) 1997-02-12
RU2129120C1 (ru) 1999-04-20
ES2116131T3 (es) 1998-07-01
HU222340B1 (hu) 2003-06-28
CN1063748C (zh) 2001-03-28
HU9601652D0 (en) 1996-08-28
ZA964652B (en) 1996-12-12
CA2178974A1 (en) 1996-12-16
CA2178974C (en) 2006-06-06
BR9602802A (pt) 1998-10-06
IL118469A0 (en) 1996-09-12
ATE164843T1 (de) 1998-04-15
NO962527L (no) 1996-12-16
MY121606A (en) 2006-02-28
EP0748805A1 (de) 1996-12-18
AU706156B2 (en) 1999-06-10
DE69600221T2 (de) 1998-08-06
US5969140A (en) 1999-10-19
EP0748805B1 (de) 1998-04-08
HK1010116A1 (en) 1999-06-11
BG62521B1 (bg) 2000-01-31
HUP9601652A1 (en) 1997-09-29

Similar Documents

Publication Publication Date Title
SG47152A1 (en) Naphthalene derivatives process for the preparation thereof and intermediates therefor
IL117188A0 (en) Process for the preparation of thietanones
IL113850A0 (en) Process and intermediates for the preparation of 3-aryluracils
HUP9602957A2 (en) Process for the preparation of dihalo- and dihidroxi-azolopyrimidines
HUP9900947A3 (en) Process for the preparation of piperidine derivatives, intermediates and preparation thereof
HUP9904034A3 (en) New process for the preparation of phenylimidazolidine derivatives
HUP9901176A3 (en) Process for the preparation of 2,2'-bipyrrolyl-pyrromethene (prodigiosins) derivatives and their intermediates
HUP9903701A3 (en) Process for the preparation of 2-chlorothiazole derivatives, intermediates and preparation thereof
HU9600320D0 (en) Process and new intermediates for the preparation of triazolinon-derivatives
IL118992A0 (en) Process and intermediates for preparing norbenzomorphan derivatives
AU639825B2 (en) Substituted 1,2,4-triazinediones, processes for their preparation, intermediates therefor and their use
HUP0003019A3 (en) Process for preparing 4-substituted-1h-indole-3-glyoxamides and their intermediates
HUP0001444A3 (en) Process for preparing carboxamido-4-azasteroids and their intermediates
HUP9903814A3 (en) Process for the preparation of pesticides, intermediates and preparation thereof
IL115090A0 (en) Process for the preparation of p-bromofluorobenzene
ZA965709B (en) Benzylhydroxylamines and intermediates for their preparation.
ZA961972B (en) 3-Aryluracils and intermediates for their preparation.
IL118747A (en) Process for the preparation of 3-hydroxyoxetanes
AU4400397A (en) Process for producing isoxazole derivatives and intermediates for producing the same
AU4708697A (en) Process for the preparation of eberconazol and intermediates thereof
IL118732A (en) Process for the preparation of arylidene-substituted alkylcycloalkanones
GB2302691B (en) Oxaindene derivatives and process for the preparation thereof
HUP9601521A3 (en) Process for preparing substituted quinoline-intermediates and the intermediates arising from the process
AU3879095A (en) Process and intermediates for preparing triphenyltrifluoropropanes and -propenes
HUP9601520A3 (en) Substituted quinoline-intermediates and process for preparation the same